SRINIVASA REDDY: Open Payments
NPI 1356437743 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 35 payments from 6 companies in 2025. Trend: 2023 $688 · 2024 $579 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $335 |
| Teva Pharmaceuticals USA, Inc. | 10 | $141 |
| E.R. Squibb & Sons, L.L.C. | 6 | $120 |
| Alkermes, Inc. | 4 | $82 |
| Janssen Pharmaceuticals, Inc | 3 | $65 |
| ABBVIE INC. | 1 | $24 |
Products named: INGREZZA, COBENFY, UZEDY, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, VRAYLAR, LYBALVI.
Industry payments across SC — which companies pay providers there.
